Close
Smartlab Europe
Achema middle east

News

RAPS announces training programme for 510(k) submissions featuring former FDA officials

The Regulatory Affairs Professionals Society (RAPS) continues its support of medical device professionals in Europe with the launch of a workshop focused on 510(k) premarket submissions to the US Food and Drug Administration (FDA). The two-day...

Autoclave Manufacturer Priorclave Celebrates 30 Years

A small specialist British engineering company called Priorclave celebrates 30 years in the design, manufacture and world-wide supply of an extensive range of laboratory and research grade autoclaves. The company has achieved considerable export success as...

World-Class Speakers Announced for Lonza’s 4th Global Endotoxin Testing Summit

Lonza has announced a panel of top endotoxin experts to present at the 4th Global Endotoxin Testing Summit from 12-14 June 2018, in Annapolis, MD (USA). This year’s event has the theme "Feel the Pulse of...

Haverford Trust Co. elevated its position in shares of Eli Lilly and Co by 16.3%

Haverford Trust Co. lifted its position in shares of Eli Lilly and Co by 16.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,105...

Cipla and Roche tie-up to sell 2 cancer drugs in India

The pharma major will distribute Tocilizumab and Syndyma -- the second brand of Roche's cancer therapy bevacizumab -- in India. This partnership is in line with Cipla and Roche's efforts to improve healthcare and increase access...

José Baselga, Named as Bristol-Myers Squibb’s M.D., Ph.D. to Board of Directors

Bristol-Myers Squibb Company announced that its Board of Directors has elected José Baselga, M.D., Ph.D., to the Board, effective March 1, 2018. Dr. Baselga will serve as a member of Science & Technology Committee of the Board of Directors....

Novartis shareholders grant all resolutions projected by Board of Directors at the Annual General Meeting

Novartis shareholders today agreed to the Board of Directors' recommendations for all proposed resolutions at the Group's Annual General Meeting (AGM). A total of 1,731 shareholders were present at the meeting held in Basel, representing approximately 62.6% of the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »